Repeat thrombolysis for acute myocardial infarction

P Banerjee1, A L Clark, M S Norell

  • 1Department of Cardiology, Castle Hill Hospital, Kingston upon Hull HU16 5JQ, UK. pbanerjee@ukonline.co.uk

Insights

Repeat thrombolysis for acute myocardial infarction identifies high-risk patients. While safe, these patients require close monitoring and potential early intervention, especially if initial treatment fails.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Research

Background:

  • Thrombolysis is the primary treatment for acute myocardial infarction (AMI) in the UK.
  • A significant number of AMI patients experience treatment failure or early re-infarction with initial thrombolysis.
  • Optimal management for these patients remains unclear, with repeat thrombolysis often administered in non-interventional facilities.

Purpose of the Study:

  • To evaluate the outcomes of repeat thrombolysis in AMI patients with failed initial treatment or early re-infarction.
  • To compare the safety and efficacy of single versus multiple thrombolytic doses.

Main Methods:

  • Retrospective analysis of 92 patients receiving two or more thrombolysis doses versus 98 patients receiving a single dose for AMI.
  • Case note review to assess outcomes including death, heart failure, and need for revascularization.

Main Results:

  • The repeat thrombolysis group showed significantly higher 30-day mortality (p=0.0016).
  • Increased incidence of heart failure with lower ejection fraction and cardiac arrests observed in the rethrombolysed group.
  • Hemorrhage rates were similar between groups; however, repeat thrombolysis led to more coronary angiography and percutaneous coronary interventions (PCIs).

Conclusions:

  • Repeat thrombolysis identifies AMI patients at high risk for early complications.
  • While repeat thrombolysis is safe, close monitoring and early intervention are crucial.
  • Early referral to tertiary centers is recommended for patients in district general hospitals without interventional facilities.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...